Podcast TCTMD Talking Points FORZA: Randomized Trial of Fractional Flow Reserve vs Optical Coherence Tomography to Guide Revascularization of Intermediate Coronary Stenoses What are the respective values of FFR and OCT in guiding revascularization? C. Michael Gibson gets a primer from Francesco Burzotta.
Podcast TCTMD Talking Points Wearables - The Future Is Now C. Michael Gibson connects with Sameer Mehta and Francisco Fernandez to hear how new tech is poised to disrupt medical care.
Podcast TCTMD Talking Points Onyx ONE: Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT C. Michael Gibson learns about the Onyx ONE trial from Stephan Windecker.
Podcast TCTMD Talking Points TWILIGHT: Ticagrelor Monotherapy vs Ticagrelor Plus Aspirin in High-Risk Patients Undergoing PCI C. Michael Gibson reviews the randomized TWILIGHT trial results with Roxana Mehran.
Podcast TCTMD Talking Points Propensity Score-Matched Analysis of Transcatheter Tricuspid Valve Treatment vs Medical Treatment in Patients With Severe Tricuspid Regurgitation Maurizio Taramasso walks C. Michael Gibson through randomized data focused on tricuspid valve disease.
Podcast TCTMD Talking Points MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable-Polymer SES C. Michael Gibson hears from Ken Kozuma about the single-arm MODEL U-SES study.
Podcast TCTMD Talking Points STS Registry: Mitral Valve Surgery Institutional Volume-Outcome Relationship in the United States Vinay Badhwar discusses new data from the STS Registry addressing volume/outcome relationships for mitral valve surgery.
Podcast TCTMD Talking Points Mitral Valve-in-Valve: 1-Year Outcomes of Transcatheter Mitral Valve Replacement for Degenerated Mitral Bioprotheses C. Michael Gibson discusses 1-year results from this high-risk patient series with Mayra Guerrero.
Podcast TCTMD Talking Points SCOPE I: ACURATE Neo vs SAPIEN 3 in Severe Aortic Stenosis Jonas Lanz walks C. Michael Gibson through the main results from this head-to-head TAVR trial.
Podcast TCTMD Talking Points REMEDIAL III: Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy C. Michael Gibsons sits down with Carlo Briguori to discuss the REMEDIAL III trial results.